The endothelium: vascular control of haemostasis

Abstract Within many general functions the endothelium is equipped with a number of mechanisms that prevent thrombus formation in the circulatory system. It harbours factors that interrupt the coagulation cascade, such as antithrombin III, the protein C receptor thrombomodulin, and tissue factor pathway inhibitor. It prevents platelet activation by the production of nitric oxide and prostacyclin, exonucleotidases and surface heparan sulphates. Furthermore, it can trigger and control fibrinolysis by the synthesis and release of tissue-type plasminogen activator and its inhibitor PAI-1. The general properties of the endothelium are subject to adaptation by environmental factors, such as inflammatory mediators and shear forces. Interleukin-1 and tumour necrosis factor-α reduce the antithrombotic properties of the endothelium. Furthermore, local variation exists between different vascular beds and vessel types, such as in the endometrium. While the endothelium controls blood fluidity on its apical side, adaptation of the endothelium also prepares its involvement in tissue repair upon inflammation or damage. The fibrin matrix, which is formed after damage of the vascular system, not only acts as a sealing of the wound, but also facilitates the repair process by providing a scaffolding for cell invasion and angiogenesis.

[1]  J. Pearson,et al.  Endothelial cell function and thrombosis. , 1994, Bailliere's best practice & research. Clinical haematology.

[2]  D. Wagner The Weibel-Palade Body: the Storage Granule for von Willebrand Factor and P-selectin , 1993, Thrombosis and Haemostasis.

[3]  C. Lockwood,et al.  A Biological Model for the Regulation of Peri-Implantational Hemostasis and Menstruation , 1996, The Journal of the Society for Gynecologic Investigation: JSGI.

[4]  B. Gustavsson,et al.  Human endothelial cell migration is stimulated by urokinase plasminogen activator:plasminogen activator inhibitor 1 complex released from endometrial stromal cells stimulated with transforming growth factor beta1; possible mechanism for paracrine stimulation of endometrial angiogenesis. , 1998, Biology of reproduction.

[5]  M. Gimbrone,et al.  Blood flow and vascular gene expression: fluid shear stress as a modulator of endothelial phenotype. , 1999, Molecular medicine today.

[6]  J. Loscalzo,et al.  Endothelial cells in physiology and in the pathophysiology of vascular disorders. , 1998, Blood.

[7]  S. Moncada Nitric oxide: discovery and impact on clinical medicine , 1999, Journal of the Royal Society of Medicine.

[8]  M. Gerritsen Functional heterogeneity of vascular endothelial cells. , 1987, Biochemical pharmacology.

[9]  C. Lockwood,et al.  Human Endometrial Endothelial Cells: Isolation, Characterization, and Inflammatory-Mediated Expression of Tissue Factor and Type 1 Plasminogen Activator Inhibitor1 , 2000, Biology of reproduction.

[10]  J. Sixma,et al.  The hemostatic plug. , 1977, Seminars in hematology.

[11]  I. Cameron,et al.  Nitric oxide in the endometrium. , 1998, Human reproduction update.

[12]  J. Emeis,et al.  An Endothelial Storage Granule for Tissue-Type Plasminogen Activator , 1997, The Journal of cell biology.

[13]  D. Collen The Plasminogen (Fibrinolytic) System , 1999, Thrombosis and Haemostasis.

[14]  A Etzioni,et al.  Of man and mouse: leukocyte and endothelial adhesion molecule deficiencies. , 1999, Blood.

[15]  J. Sixma,et al.  Platelet Adhesion to Collagen: an Update , 1997, Thrombosis and Haemostasis.

[16]  T. Ny,et al.  Plasminogen activators in the human endometrium, cellular origin and hormonal regulation , 1992, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[17]  H. Dvorak Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. , 1986, The New England journal of medicine.

[18]  R. Ross,et al.  Atherosclerosis is an inflammatory disease. , 1998, American heart journal.

[19]  M. Gimbrone Vascular Endothelium in Hemostasis and Thrombosis , 1987 .

[20]  P. Grant,et al.  Plasminogen-activator inhibitor type 1 and coronary artery disease. , 2000, The New England journal of medicine.

[21]  C. Esmon,et al.  The roles of protein C and thrombomodulin in the regulation of blood coagulation. , 1984, The Journal of biological chemistry.

[22]  Z. Ruggeri Mechanisms Initiating Platelet Thrombus Formation , 1997, Thrombosis and Haemostasis.

[23]  R. Busse,et al.  Pulsatile Stretch and Shear Stress: Physical Stimuli Determining the Production of Endothelium-Derived Relaxing Factors , 1998, Journal of Vascular Research.

[24]  G. Krikun,et al.  Effects of thrombin on steroid-modulated cultured endometrial stromal cell fibrinolytic potential. , 1996, The Journal of clinical endocrinology and metabolism.

[25]  A. Mantovani,et al.  Cytokine regulation of endothelial cell function: from molecular level to the bedside. , 1997, Immunology today.

[26]  K Fujikawa,et al.  The coagulation cascade: initiation, maintenance, and regulation. , 1991, Biochemistry.

[27]  W. Owen,et al.  Interactions of Thrombin with Endothelium , 1982 .

[28]  S. Rapaport,et al.  The Tissue Factor Pathway: How It Has Become a “Prima Ballerina” , 1995, Thrombosis and Haemostasis.

[29]  V. Hinsbergh Endothelial Permeability for Macromolecules Mechanistic Aspects of Pathophysiological Modulation , 1997 .

[30]  V. V. van Hinsbergh,et al.  Role of fibrin and plasminogen activators in repair-associated angiogenesis: in vitro studies with human endothelial cells. , 1997, EXS.

[31]  M. Iruela-Arispe,et al.  Endometrial Endothelial Cells Express Estrogen and Progesterone Receptors and Exhibit a Tissue Specific Response to Angiogenic Growth Factors , 1999, Microcirculation.